Jaime Alen-Calvo
Gasteiz / Vitoria, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Update to the Sociedad Española de Reumatología Guidelines on the Use of Biological Therapy in Systemic Lupus Erythematosus.
Journal: Reumatologia clinica
Published: April 18, 2026
Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort.
Journal: Lupus science & medicine
Published: March 17, 2026
Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data network.
Journal: Lupus science & medicine
Published: November 07, 2025
Does adding concomitant immunosuppressive therapy to belimumab provide additional benefits in SLE? Results from the BEL-Spain Registry.
Journal: Rheumatology (Oxford, England)
Published: September 15, 2025
Self-reported depression on the Lupus Impact Tracker questionnaire (LIT) is associated with glucocorticoid use and fibromyalgia in systemic lupus erythematosus, according to RELESSER-PROS registry data.
Journal: BMC rheumatology
Published: September 12, 2025
Real-world experience of anifrolumab in 30 patients with refractory DM: a multicentre-multidisciplinary retrospective study.
Journal: Rheumatology (Oxford, England)
Published: August 27, 2025
Real-world experience of anifrolumab in 30 patients with refractory dermatomyositis: a multicenter-multidisciplinary retrospective study.
Journal: Rheumatology (Oxford, England)
Published: August 27, 2025
Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality.
Journal: Lupus science & medicine
Published: August 06, 2025
Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study.
Journal: Seminars in arthritis and rheumatism
Published: May 08, 2025
Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort.
Journal: Lupus science & medicine
Published: April 13, 2025
Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS data.
Journal: Lupus science & medicine
Published: April 09, 2025
Last Updated: 09/26/2026